Recently, NSD2 (aka MMSET), a methyl transferase, was identified as a direct target of AURKA in MM, which unraveled the mechanism by which the AURKA-NSD2 feedback loop promotes chemoresistance. Here, NSD2 is linked to Miyoshi myopathy.